Schizophrenia Clinical Trials

Showing 721-740 of 1,356 trials

rTMS Treatment for Positive and Negative Symptoms of Schizophrenia

NCT03413527

This study will examine the effects of rTMS on the negative and positive symptoms of schizophrenia using 2 treatments in sequence applied to related brain areas.

Schizophrenia

St. Joseph's Healthcare Hamilton20 participantsStarted Feb 2016

Hamilton, Ontario, Canada

COMPLETEDPhase 2

The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms

NCT02928965

The purpose of this study is to investigate if minocycline limits the development of negative symptoms in early psychosis and to test via what mechanism of action this change occurs.

Schizophrenia and Disorders With Psychotic Features

University of Manchester207 participantsStarted Feb 2013

COMPLETEDPhase 4

Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy

NCT01609153

A study to examine whether an antipsychotic combination treatment of olanzapine and amisulpride is more effective than olanzapine and amisulpride alone.

SchizophreniaSchizoaffective Disorder

Heinrich-Heine University, Duesseldorf328 participantsStarted Jun 2012

Aachen, Germany • Alzey, Germany • Andernach, Germany +18 more locations

rTMS Treatment for Positive and Negative Symptoms of Schizophrenia

The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms

Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy

Related Searches

Multi-center Imaging Genetics Studies in China

Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia

Validation of Receptor Occupancy Simulation

Behavior During Experimentally Induced Pain

The Optimal Treatment for Treatment-resistant Schizophrenia

RCT Examining the Effectiveness of Digital Picture Frame Use in Inpatient Setting

Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch

An Evaluation of a Psychoeducation Program in Individuals Diagnosed With Schizophrenia

A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Subjects With Schizophrenia

A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia

The Role of Personal Identity in Psychotic Symptoms: a Study With the Repertory Grid Technique

Transcranial Direct Current Stimulation (tDCS) as a Treatment for Cognitive Deficits in Schizophrenic

Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole

Exercise and Overnight Motor Sequence Task

Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia

Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and Functional Magnetic Resonance Imaging (fMRI) Studies of Schizophrenia and Depression

Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis